You are here: All Products  > Germany's Merck Says Erbitux Meets Endpoints in China Phase III Trial

Germany's Merck Says Erbitux Meets Endpoints in China Phase III Trial

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products